Human Immunodeficiency Virus-Associated Lymphoproliferative Disorders

Surg Pathol Clin. 2019 Sep;12(3):771-782. doi: 10.1016/j.path.2019.03.005. Epub 2019 May 17.

Abstract

HIV infection is associated with an increased risk for developing B-cell lymphoproliferative disorders. The spectrum of disease differs in HIV-infected versus HIV-uninfected persons, with aggressive B-cell non-Hodgkin lymphomas constituting a higher proportion of all lymphoproliferative disorders in the HIV-positive population. Although antiretroviral therapy (ART) has significantly changed the landscape of lymphomas arising in HIV-infected persons, population growth and aging are reflected in the steady increase in non-AIDS-defining cancers. In the ART era, outcomes for HIV-infected lymphoma patients are similar to those of HIV-negative patients. This article reviews the diagnostic features and summarizes current biologic understanding of HIV-associated lymphomas.

Keywords: B-cell lymphoma; Epstein-Barr virus; HIV; HIV-associated Lymphoma.

Publication types

  • Review

MeSH terms

  • Anti-HIV Agents / therapeutic use
  • Burkitt Lymphoma / pathology
  • Burkitt Lymphoma / virology
  • Diagnosis, Differential
  • HIV Infections / drug therapy
  • HIV Infections / pathology*
  • Hodgkin Disease / pathology
  • Hodgkin Disease / virology
  • Humans
  • Lymphoma, AIDS-Related / pathology
  • Lymphoma, B-Cell / pathology
  • Lymphoma, B-Cell / virology*
  • Lymphoma, Primary Effusion / pathology
  • Lymphoma, Primary Effusion / virology
  • Plasmablastic Lymphoma / pathology
  • Plasmablastic Lymphoma / virology

Substances

  • Anti-HIV Agents